Home
Paradigm Biocapital Advisors reported a 6.1% stake in Maze Therapeutics MAZE · 3,051,087 sh · passive holder
Trade details
- Type
- 5% stake report
- Report
- 13G passive
- Stake
- 6.1%
- Last report
- First report
- Shares held
- 3,051,087 sh
- Class
- Common Stock, $0.001 par value per share
- Event date
- 26/03/25
- Filed
- 26/04/01
First 5%+ report · 6.1% stake
Maze Therapeutics trades, last 26 weeks
What else happened in Maze Therapeutics around then
Filed or reported within 30 days of the trade day · 02/23~04/24Paradigm Biocapital Advisors's other 5% stake reports
- Paradigm Biocapital Advisors
5% stakeSpyre Therapeutics
5% stakeSpyre Therapeutics
SYRE
5.1% stake
4,457,450 sh
5.1% stake
Filed 10/01
- Paradigm Biocapital Advisors
5% stakeTyra Biosciences
5% stakeTyra Biosciences
TYRA
5.8% stake
3,473,453 sh
5.8% stake
Filed 09/17
- Paradigm Biocapital Advisors
5% stakeAssembly Biosciences
5% stakeAssembly Biosciences
ASMB
7.8% stake
1,553,748 sh
7.8% stake
Filed 08/14
- Paradigm Biocapital Advisors
5% stakeViridian Therapeutics, Inc.\DE
5% stakeViridian Therapeutics, Inc.\DE
VRDN
6.1% stake
6,723,788 sh
6.1% stake
Filed 08/14
- Paradigm Biocapital Advisors
5% stakeLexeo Therapeutics
5% stakeLexeo Therapeutics
LXEO
5.3% stake
4,175,382 sh
5.3% stake
Filed 08/14
